Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.43 |
| ▸ | ESR1 | P03372 | 7/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | GLB1 | P16278 | 1/20 | 0.42 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.42 |
| ▸ | CTRC | Q99895 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorocresol SCHEMBL29377724 | 0.87 | — | — | |
| Chlorocresol SCHEMBL12344 | 0.87 | — | — | |
| Chlorocresol SCHEMBL6552674 | 0.87 | HSD17B10 (0.59) | ALOX15HSD17B10CYP3A4CHRM1MAOA | |
| Chlorocresol SCHEMBL28185631 | 0.85 | HSD17B10 (0.56) | ALOX15HSD17B10CYP3A4CHRM1MAOA | |
| Chlorocresol SCHEMBL1712039 | 0.85 | HSD17B10 (0.56) | ALOX15HSD17B10CYP3A4CHRM1MAOA | |
| Chlorocresol SCHEMBL29353909 | 0.85 | HSD17B10 (0.56) | ALOX15HSD17B10CYP3A4CHRM1MAOA | |
| Chlorocresol SCHEMBL1712038 | 0.85 | HSD17B10 (0.56) | ALOX15HSD17B10CYP3A4CHRM1MAOA | |
| Chlorocresol SCHEMBL9396313 | 0.85 | HSD17B10 (0.56) | ALOX15HSD17B10CYP3A4CHRM1MAOA | |
| Chlorocresol SCHEMBL10688541 | 0.83 | HSD17B10 (0.50) | ALOX15HSD17B10CYP3A4CHRM1MAOA | |
| Chlorocresol SCHEMBL11041971 | 0.83 | HSD17B10 (0.54) | ALOX15HSD17B10CYP3A4CHRM1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1879457-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | Ciba Specialty Chemicals Holding, Inc. (CH) | 2008-01-23 | — | — | EP | claimed |
| WO-2006120135-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-16 | — | — | WO | claimed |
| US-20240041739-A1 | BIOPHOTONIC COMPOSITIONS AND METHODS FOR PROVIDING BIOPHOTONIC TREATMENT | KLOX TECHNOLOGIES INC. (CA) | 2024-02-08 | — | — | US | disclosed |
| US-11723854-B2 | Biophotonic compositions and methods for providing biophotonic treatment | FLE INTERNATIONAL S.R.L. (IT) | 2023-08-15 | — | — | US | disclosed |
| US-20220387592-A1 | BIOPHOTONIC COMPOSITIONS AND METHODS FOR PROVIDING BIOPHOTONIC TREATMENT | FLE INTERNATIONAL S.R.L. (IT) | 2022-12-08 | — | — | US | disclosed |
| US-20220296713-A1 | BIOPHOTONIC COMPOSITIONS FOR TREATING SKIN AND SOFT TISSUE WOUNDS HAVING EITHER OR BOTH NON-RESISTANT AND RESISTANT INFECTIONS | KLOX TECHNOLOGIES LIMITED (IE) | 2022-09-22 | — | — | US | disclosed |
| US-11382977-B2 | Biophotonic compositions for treating skin and soft tissue wounds having either or both non-resistant and resistant infections | VETOQUINOL S.A. (FR) | 2022-07-12 | — | — | US | disclosed |
| US-11331257-B2 | Biophotonic compositions and methods for providing biophotonic treatment | KLOX TECHNOLOGIES INC. (CA) | 2022-05-17 | — | — | US | disclosed |
| US-11324823-B2 | Biophotonic materials and uses thereof | KLOX TECHNOLOGIES INC. (CA) | 2022-05-10 | — | — | US | disclosed |
| EP-3151861-B1 | SILICONE-BASED BIOPHOTONIC COMPOSITIONS AND USES THEREOF | KLOX TECH INC (CA) | 2022-04-06 | — | — | EP | disclosed |
| US-20220023181-A1 | PEROXIDE-LESS BIOPHOTONIC COMPOSITIONS AND METHODS | KLOX TECHNOLOGIES LIMITED | 2022-01-27 | — | — | US | disclosed |
| US-20130281913-A1 | BIOPHOTONIC COMPOSITIONS AND METHODS FOR PROVIDING BIOPHOTONIC TREATMENT | KLOX TECHNOLOGIES INC. (CA) | 2013-10-24 | — | — | US | disclosed |
| US-20120225027-A1 | TOXICITY ENHANCING COMPOUNDS AND METHODS | CASE WESTERN RESERVE UNIVERSITY | 2012-09-06 | — | — | US | disclosed |
| WO-2012040710-A2 | STABILIZED NANOBUBBLES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | CASE WESTERN RESERVE UNIVERSITY (US) | 2012-03-29 | — | — | WO | disclosed |
| EP-1879457-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | Ciba Specialty Chemicals Holding, Inc. (CH) | 2008-01-23 | — | — | EP | disclosed |
| US-20070231295-A1 | Antimicrobial Silicon Oxide Flakes | CIBA SPECIALTY CHEMICALS CORP. | 2007-10-04 | — | — | US | disclosed |
| WO-2006120135-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-16 | — | — | WO | disclosed |
| US-20040009227-A1 | Thermoplastic particles which comprise an antiviral or antimicrobial agent | POREX CORPORATION | 2004-01-15 | — | — | US | disclosed |
| US-20020187176-A1 | Porous plastic media with antiviral or antimicrobial properties and processes for making the same | POREX CORPORATION | 2002-12-12 | — | — | US | disclosed |
| WO-2001065937-A1 | POROUS PLASTIC MEDIA WITH ANTIVIRAL OR ANTIMICROBIAL PROPERTIES AND PROCESSES FOR MAKING THE SAME | POREX TECHNOLOGIES CORPORATION (US) | 2001-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070231295-A1 | Antimicrobial Silicon Oxide Flakes | SIK2, SIK3, SIK1 | ALOX15 527/4885HSD17B10 3334/4885CYP3A4 2310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.